These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31597437)

  • 21. Letter to the Editor: Bone Health in Nonalcoholic Fatty Liver Disease: A Mechanistic Insight.
    Sugiyama T
    Hepatology; 2019 Nov; 70(5):1872. PubMed ID: 31099070
    [No Abstract]   [Full Text] [Related]  

  • 22. The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
    Yayla Ç; Yayla KG; Karanfil M; Ertem AG; Ünal S; Erdöl MA; Demirtaş K; Akdi A; Çöteli C; Özilhan MO; Karaaslan ÖÇ
    Angiology; 2020 Jan; 71(1):87. PubMed ID: 31319680
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease.
    Luo L; Zou H; Zheng S; Duan Z; Chen Y
    Hepatology; 2019 Oct; 70(4):1492-1493. PubMed ID: 31152594
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease.
    Gawrieh S; Kleiner DE; Chalasani N; Vanderbeck S
    Hepatology; 2020 Aug; 72(2):785. PubMed ID: 32043611
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Mendelian randomisation to investigate moderate alcohol consumption in nonalcoholic fatty liver disease; modest effects need large numbers-authors' reply.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2017 Aug; 46(4):469-470. PubMed ID: 28707786
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to "Establishing the independence and clinical importance of non-alcoholic fatty liver disease as a risk factor for cardiovascular disease".
    Pais R; Ratziu V
    J Hepatol; 2016 Dec; 65(6):1267-1268. PubMed ID: 27498133
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease and Mortality.
    Stefan N
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1043-1045. PubMed ID: 29474973
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes".
    Zaccardi F; Morrison AE; Khunti K; Davies MJ
    Liver Int; 2019 Apr; 39(4):780-781. PubMed ID: 30615269
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome.
    Miele L; Gasbarrini G; Giorgio V; Gasbarrini A; Grieco A
    Intern Emerg Med; 2016 Feb; 11(1):3-10. PubMed ID: 26602387
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis.
    Mahfood Haddad T; Hamdeh S; Kanmanthareddy A; Alla VM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S209-S216. PubMed ID: 28017631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B.
    Huang R; Wang J; Zhang Z; Yan X; Wu C
    Hepatology; 2020 Feb; 71(2):767. PubMed ID: 31587343
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter to the Editor: Nonalcoholic Fatty Liver Disease-One Size May Not Fit All.
    Wilson A; Beaton M; Brahmania M
    Hepatology; 2021 Jul; 74(1):528. PubMed ID: 32965684
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram.
    Targher G; Byrne CD
    Hepatology; 2016 Aug; 64(2):684-5. PubMed ID: 26486720
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications.
    Boutari C; Lefkos P; Athyros VG; Karagiannis A; Tziomalos K
    Curr Vasc Pharmacol; 2018; 16(3):214-218. PubMed ID: 28676025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.
    Chacko KR; Reinus J
    Clin Liver Dis; 2016 May; 20(2):387-401. PubMed ID: 27063276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-Based Differences in the Association Between Nonalcoholic Fatty Liver Disease and Mortality.
    Ye ZL; Guo WQ; Li L
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):211-212. PubMed ID: 30099111
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey - author's reply.
    Wong RJ
    Aliment Pharmacol Ther; 2018 Sep; 48(5):585-586. PubMed ID: 30156318
    [No Abstract]   [Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea?
    Mirrakhimov AE; Mirrakhimov EM
    Can J Cardiol; 2013 Sep; 29(9):1139.e7. PubMed ID: 23265092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.